Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Gujarat Themis Biosyn Ltd ( (IN:GUJTHEM) ).
Gujarat Themis Biosyn Limited has reported to the stock exchanges that, under SEBI’s special window framework for re-lodgement of transfer requests of physical shares for transfer-cum-demat, there were no such re-lodgement cases received in December 2025. The disclosure, based on confirmation from its registrar and transfer agent MUFG Intime India Private Limited, indicates no pending physical share transfer issues for that period, suggesting stable share transfer operations and regulatory compliance for investors holding physical securities.
More about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Limited is an Indian pharmaceutical company based in Vapi, Gujarat, with additional offices in Mumbai. It operates in the biosciences sector, focusing on manufacturing pharmaceutical products and serving investors through listings on BSE and NSE under the scrip code 506879 and symbol GUJTHEM, respectively.
Average Trading Volume: 12,538
Technical Sentiment Signal: Buy
Current Market Cap: 41.34B INR
See more data about GUJTHEM stock on TipRanks’ Stock Analysis page.